alexa Interferon Gamma/IL10 Ratio Production in Response to H
ISSN: 2329-6917

Journal of Leukemia
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Interferon Gamma/IL10 Ratio Production in Response to Host Antigens may Predict Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation from a Sibling

Azza M Kamel1*, Nahla M El-Sharkawy1, Eman K Abd El-Fattah1, Raafat M Abd El-Fattah2, Mohammed A Samra2, Paul K Wallace3 and Hossam K Mahmoud2

1Department of Clinical Pathology, NCI, Cairo University, Egypt

2Department of Medical oncology, NCI, Cairo University, Egypt

3Flow Cytometry Lab, Roswell Park Cancer Institute, USA

*Corresponding Author:
Azza M Kamel
Department of Clinical Pathology
NCI, Cairo University, Egypt
Tel: (2)01005184937
Fax: (202)23644720
E-mail: [email protected]

Received date March 26, 2013; Accepted date May 16, 2013; Published date May 20, 2013

Citation: Kamel AM, El-Sharkawy NM, Abd El-Fattah EK, Abd El-Fattah RM, Samra MA, et al. (2013) Interferon Gamma/IL10 Ratio Production in Response to Host Antigens may Predict Acute Graft Versus Host Disease after Allogeneic Stem Cell Transplantation from a Sibling. J Leuk (Los Angel) 1:111. doi: 10.4172/2329-6917.1000111

Copyright: © 2013 Kamel AM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Background: Graft versus host disease (GVHD) continues to be the main concern of transplanters. Cytokines’ contribution to its pathogenesis has been widely addressed in the literature. Previous studies have mainly evaluated the cytokine’s level after the actual occurrence of GVHD. In this work, we investigated the possibility of predicting the occurrence of acute GVHD through an experimental setup to mimic the response of the immune cells of the graft to the host antigens expressed by interferon gamma (IFNγ) and interleukin 10 (IL10) production. Methods: The study included 45 patients receiving allogeneic HSCT from an identical sibling. An aliquot from the graft prior to infusion was used for in vitro culture for 3 days with patients’ mitomycin treated mononuclear cells. IFNγ and IL10 were measured in culture supernatant using microbead array technology. Results: Acute GVHD was encountered in 14 cases. IFNγ was detectable in the culture supernatant of 9/14 (64.3%) cases with GVHD at a level of 6.2 - 19.000 with a median of 159.3 pg/ml versus 3/31 (9.6%) cases without GVHD at a level of 1.1, 8.1 and 80.01 pg/ml (p<0.001). IL10 was detectable in the culture supernatant of 7/14 (50%) cases with GVHD at a level of 9.5 – 858.5 with a median of 128 pg/ml versus 6/31 (19.3%) cases without GVHD at a level of 14.0 – 359.0 with a median of 45.39 pg/ml (p<0.05). At a cutoff of 1.13, IFNγ/IL10 ratio could predict GVHD with a sensitivity of 85.7%, specificity of 83.3% and a total accuracy of 84.6%. Conclusion: In vitro cytokine production by graft immune cells in response to host antigens is extremely variable. IFNγ production apparently reflects potential development of acute GVHD while IL10 production is apparently protective. When both are produced the IFNγ/IL10 ratio is more informative than either alone.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords